Breakthrough in Membrane Protein Simulation: MPBuild Pipeline Paves the Way for High-Throughput Drug Discovery

Strategic Insights -

Researchers from the Macau University of Science and Technology have developed a novel pipeline, MPBuild, that facilitates the high-fidelity simulation of membrane proteins, which serve as targets for 50% of FDA-approved drugs. The automated pipeline streamlines the system preparation process, enabling rapid characterization of these proteins via molecular dynamics simulation. This breakthrough has significant implications for the high-throughput drug discovery process, offering an end-to-end solution from system preparation to simulation.

Key Takeaways:

  • MPBuild is an automated pipeline that integrates structural repair, noncanonical component parametrization, and system assembly to facilitate the simulation of membrane proteins.
  • The pipeline achieves processing times comparable to those of CHARMM-GUI when structural repair durations are excluded, with a benchmark of 11 diverse membrane protein systems.
  • Case studies validate the biophysical accuracy of MPBuild, reproducing binding interfaces of GPR68-G, accurately capturing SSTR2/5 and octreotide interactions, and suggesting potential novel motifs.
  • The pipeline offers an end-to-end solution for high-throughput membrane protein drug discovery, streamlining the entire process from system preparation to simulation.
  • Key innovations in MPBuild include template-guided restoration of wild-type sequences and missing domains, automated force field generation for complex ligands, and decomposed PDB outputs enabling minute-scale system rebuilding.
  • The pipeline is a powerful tool for molecular dynamics simulation, enabling the characterization of membrane proteins in a high-throughput manner.

Statistics:

  • 50% of FDA-approved drugs target membrane proteins.
  • 11 diverse membrane protein systems were used as benchmarks for MPBuild.
  • MPBuild achieved processing times comparable to those of CHARMM-GUI when structural repair durations were excluded.
  • The pipeline achieved accurate biophysical results, reproducing binding interfaces and capturing complex ligand interactions.
  • Eligible manuscripts may be found at www.pubs.acs.org/journal/jctcce.

Sources:

  • MPBuild: An Automated Pipeline for High-Fidelity Membrane Protein Simulation System Construction. Journal of Chemical Theory and Computation, 2025.
  • Life Science Weekly. November 4, 2025; p 6061.
  • Amer Chemical Soc, 1155 16TH St, NW, Washington, DC 20036, USA (Journal of Chemical Theory and Computation contact)
  • Macau University of Science and Technology, Macau 999078, People's Republic of China (Wei Ding and Dr. Neher's Biophysics Laboratory for Innovative Drug Discovery)